Evidence map›Paper›PMID 37594261›Full record

ArticlemSphere2023

Rapid, efficient auxin-inducible protein degradation in

Kedric L Milholland, Justin B Gregor, Smriti Hoda, Soledad Píriz-Antúnez, Encarnación Dueñas-Santero, Bao Gia Vu, Krishna P Patel, W Scott Moye-Rowley, Carlos R Vázquez de Aldana, Jaime Correa-Bordes and 2 more

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Roles of P-body factors inbioRxiv : the preprint server for biology · 2025
    Article
  9. Article
  10. Article
  11. Inducible degradation-coupled phosphoproteomics identifies PP2AFrontiers in cell and developmental biology · 2024
    Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Kedric L MilhollandDepartment of Biochemistry, Purdue University , West Lafayette, Indiana, USA.
Justin B GregorDepartment of Biochemistry, Purdue University , West Lafayette, Indiana, USA.
Smriti HodaDepartment of Biochemistry, Purdue University , West Lafayette, Indiana, USA.
Soledad Píriz-AntúnezDepartment of Biomedical Sciences, Universidad de Extremadura , Badajoz, Spain.
Encarnación Dueñas-SanteroInstitute of Functional Biology and Genomics, Consejo Superior de Investigaciones Científicas (CSIC), Universidad de Salamanca (USAL) , Salamanca, Spain.
Bao Gia VuDepartment of Molecular Physiology and Biophysics, Carver College of Medicine, University of Iowa , Iowa City, Iowa, USA.
Krishna P PatelDepartment of Biochemistry, Purdue University , West Lafayette, Indiana, USA.
W Scott Moye-RowleyDepartment of Molecular Physiology and Biophysics, Carver College of Medicine, University of Iowa , Iowa City, Iowa, USA.ORCID 0000-0002-7163-1120
Carlos R Vázquez de AldanaInstitute of Functional Biology and Genomics, Consejo Superior de Investigaciones Científicas (CSIC), Universidad de Salamanca (USAL) , Salamanca, Spain.
Jaime Correa-BordesDepartment of Biomedical Sciences, Universidad de Extremadura , Badajoz, Spain.
Scott D BriggsDepartment of Biochemistry, Purdue University , West Lafayette, Indiana, USA.ORCID 0000-0003-2852-3594
Mark C HallDepartment of Biochemistry, Purdue University , West Lafayette, Indiana, USA.ORCID 0000-0001-6429-2506
Purdue University West Lafayette · USConsejo Superior de Investigaciones Científicas · ESUniversidad de Extremadura · ESUniversity of Iowa · US

Funding

Transgenic Mouse Core Facility Shared Resource (TMCF-SR)P30CA023168 · NCI · PURDUE UNIVERSITY WEST LAFAYETTE · PI Andrea L Kasinski · 1985 to 2026
$43.4M
Quality Assurance and Quality Control Project Management: Improving Submissions and Study Conduct in the Human Subjects Research Prior Approval ProcessUL1TR002529 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI MOE, SHARON M, WIEHE, SARAH ELIZABETH · 2018 to 2022
$27.2M
Cdc14 phosphatase - novel roles in drug resistance, virulence, and the response to cell wall stress in fungal pathogensR01AI168050 · NIAID · PURDUE UNIVERSITY · PI Mark C Hall · 2023 to 2026
$2.4M
Genetic analysis of pleiotropic drug resistanceR01AI152494 · NIAID · UNIVERSITY OF IOWA · PI MOYE-ROWLEY, W SCOTT · 2020 to 2024
$2.1M
SET Domain Epigenetic Factors Govern Antifungal Drug Efficacy and Fungal PathogenesisR01AI136995 · NIAID · PURDUE UNIVERSITY · PI BRIGGS, SCOTT D · 2018 to 2022
$1.9M
Drug Discovery in Infectious Disease TrainingT32AI148103 · NIAID · PURDUE UNIVERSITY · PI STAHELIN, ROBERT VIRGIL, YEO, YOON · 2020 to 2024
$949k
Development and application of auxin-inducible degradation in Candida pathogensR21AI174123 · NIAID · PURDUE UNIVERSITY · PI HALL, MARK C · 2023 to 2024
$423k
NCATS NIH HHS UL1 TR002529NCI NIH HHS P30 CA023168NIAID NIH HHS R01 AI136995NIAID NIH HHS R01 AI152494NIAID NIH HHS R01 AI168050NIAID NIH HHS R21 AI174123NIAID NIH HHS T32 AI148103
6 · The paper itself

Abstract

A variety of inducible protein degradation (IPD) systems have been developed as powerful tools for protein functional characterization. IPD systems provide a convenient mechanism for rapid inactivation of almost any target protein of interest. Auxin-inducible degradation (AID) is one of the most common IPD systems and has been established in diverse eukaryotic research model organisms. Thus far, IPD tools have not been developed for use in pathogenic fungal species. Here, we demonstrate that the original AID and the second generation, AID2, systems work efficiently and rapidly in the human pathogenic yeasts,

Indexed as

CandidaMycosesCandida albicansCandida glabrataHumansProteolysisauxin-inducible degradationCandida albicansCandida glabrataCdc14Gcn5Mob2targeted protein degradation

Identifiers

PMID37594261
PMCPMC10597344
OpenAlexW4385969112

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.